You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Details for Patent: 10,842,766


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,842,766 protect, and when does it expire?

Patent 10,842,766 protects VASCEPA and is included in one NDA.

This patent has fifty patent family members in twenty-seven countries.

Summary for Patent: 10,842,766
Title:Stable pharmaceutical composition and methods of using same
Abstract: The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
Inventor(s): Manku; Mehar (Birmingham, GB), Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/696,627
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a Patent: A Detailed Guide Using US Patent 10,842,766 as an Example

Introduction

When analyzing a patent, understanding the scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the intricacies of patent scope and claims, using US Patent 10,842,766 as a case study.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is a critical aspect of patent quality and can significantly affect innovation and litigation costs[3].

Metrics for Measuring Patent Scope

Researchers often use simple metrics such as independent claim length and independent claim count to measure patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

The Role of Claims in a Patent

Claims are the heart of a patent, defining the invention and the scope of protection. They must be clear, concise, and exact to meet statutory requirements.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Importance of Claim Clarity

Clear claims are essential for ensuring that the patent meets statutory requirements and can be upheld if challenged. The USPTO has faced challenges with broadly worded patent applications, which can make thorough examinations difficult. Nearly 90% of patent examiners encounter such issues, highlighting the need for tools like glossaries of key terms or claim charts to enhance clarity[1].

Analyzing US Patent 10,842,766

Patent Overview

To analyze US Patent 10,842,766, one must first understand the invention it describes. This involves reading the abstract, description, and claims.

Claim Structure

  • Independent Claims: Identify the independent claims, which define the core of the invention.
  • Dependent Claims: Analyze how the dependent claims further limit the independent claims, adding specificity to the invention.

Claim Language

Examine the language used in the claims. Are the terms clear, concise, and exact? The use of ambiguous terms can lead to disputes over the patent's scope.

Tools for Patent Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for analyzing patents. It provides enhanced access to prior art and allows users to search through various databases, including PubEast and PubWest, which have been replaced by the new tool[4].

Global Dossier

This service allows users to view the file histories of related applications from participating IP Offices, providing a comprehensive view of the patent family and related citations[4].

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, helping to visualize search results on a single page[4].

Impact of Patent Scope on Innovation and Litigation

Broad vs. Narrow Claims

Research indicates that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. Broad claims, on the other hand, can lead to increased litigation costs and diminished incentives for innovation[3].

Economic Implications

The scope of a patent can have significant economic implications. Overly broad patents can lead to patent thickets, where multiple patents cover similar inventions, increasing licensing and litigation costs. This can stifle innovation by making it more difficult for new entrants to navigate the patent landscape[3].

Best Practices for Ensuring Patent Quality

Consistent Definition of Patent Quality

The USPTO should consistently define patent quality and articulate this definition in agency documents and guidance. This aligns with federal internal-control standards and best practices for organizational performance[1].

Use of Clarity Tools

While the USPTO has considered requiring applicants to use claim clarity tools, such as glossaries or claim charts, stakeholders have not supported this requirement. However, using such tools can significantly improve the clarity of patent applications[1].

Time Allotted for Examination

Ensuring that examiners have sufficient time to perform thorough examinations is crucial. The USPTO has increased the time available for certain art units, reflecting the complexity of some technology areas[1].

Case Study: US Patent 10,842,766

Claim Analysis

For US Patent 10,842,766, start by identifying the independent claims and analyzing their language for clarity and specificity. Check if the dependent claims add meaningful limitations to the independent claims.

Prior Art Search

Use the Patent Public Search tool and Global Dossier to identify prior art and related applications. This helps in understanding the patent's position within the broader patent landscape.

Economic Impact

Consider the economic implications of the patent's scope. Are the claims narrow and specific, or are they broad and potentially contentious? This analysis can help predict the patent's impact on innovation and litigation costs.

Key Takeaways

  • Clear Claims: Clear and concise claims are essential for ensuring patent quality and enforceability.
  • Patent Scope Metrics: Metrics like independent claim length and count can help measure patent scope.
  • Tools for Clarity: Tools such as glossaries and claim charts can enhance claim clarity, though their mandatory use is not currently supported by stakeholders.
  • Economic Implications: The scope of a patent can significantly impact innovation and litigation costs.
  • Best Practices: Consistent definition of patent quality and adequate examination time are crucial for ensuring high-quality patents.

FAQs

Q: What is the importance of claim clarity in a patent?

A: Claim clarity is crucial for ensuring that the patent meets statutory requirements and can be upheld if challenged. Clear claims help in avoiding disputes and litigation.

Q: How does the USPTO measure patent quality?

A: The USPTO uses correctness measures and quantifiable compliance targets to measure patent quality. These measures include statutory compliance rates for various sections of the U.S. Code[1].

Q: What are the economic implications of broad patent claims?

A: Broad patent claims can lead to increased licensing and litigation costs, potentially stifling innovation by making it more difficult for new entrants to navigate the patent landscape[3].

Q: What tools does the USPTO provide for patent search and analysis?

A: The USPTO provides tools such as the Patent Public Search, Global Dossier, and Common Citation Document to facilitate thorough patent searches and analyses[4].

Q: Why is a consistent definition of patent quality important?

A: A consistent definition of patent quality helps the USPTO to fully measure progress toward meeting its patent quality goals and aligns with federal internal-control standards and best practices[1].

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess Incentives, and Improve Application Review Process. GAO-16-490.
  2. USAGov: U.S. Patent and Trademark Office (USPTO).
  3. SSRN Paper: Patent Claims and Patent Scope.
  4. USPTO: Search for patents.
  5. ACUS Report: U.S. Patent Small Claims Court Study.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,842,766

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF STROKE IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDES AND ATRIAL FIBRILLATION ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF STROKE IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDES AND ATRIAL FIBRILLATION ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,842,766

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010241571 ⤷  Try for Free
Brazil PI1011876 ⤷  Try for Free
Canada 2759284 ⤷  Try for Free
China 102458109 ⤷  Try for Free
China 104856985 ⤷  Try for Free
Colombia 6470838 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.